Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for Foghorn Therapeutics (FHTX) over the last 4 years, with Q3 2025 value amounting to $2.0 million.

  • Foghorn Therapeutics' Interest & Investment Income fell 4185.98% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 1164.52%. This contributed to the annual value of $11.9 million for FY2024, which is 942.53% up from last year.
  • According to the latest figures from Q3 2025, Foghorn Therapeutics' Interest & Investment Income is $2.0 million, which was down 4185.98% from $2.3 million recorded in Q2 2025.
  • Foghorn Therapeutics' 5-year Interest & Investment Income high stood at $3.5 million for Q3 2024, and its period low was $235000.0 during Q1 2022.
  • Moreover, its 4-year median value for Interest & Investment Income was $2.7 million (2023), whereas its average is $2.4 million.
  • Per our database at Business Quant, Foghorn Therapeutics' Interest & Investment Income soared by 103574.47% in 2023 and then crashed by 4185.98% in 2025.
  • Foghorn Therapeutics' Interest & Investment Income (Quarter) stood at $2.4 million in 2022, then rose by 11.95% to $2.7 million in 2023, then rose by 16.39% to $3.1 million in 2024, then plummeted by 34.37% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.3 million for Q2 2025, and $2.7 million during Q1 2025.